PlainRecalls
FDA Drug Moderate Class II Terminated

Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01

Reported: December 26, 2012 Initiated: November 21, 2012 #D-096-2013

Product Description

Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01

Reason for Recall

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Details

Recalling Firm
Hospira, Inc.
Units Affected
145,400 vials
Distribution
Nationwide and Puerto Rico.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01. Recalled by Hospira, Inc.. Units affected: 145,400 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 26, 2012. Severity: Moderate. Recall number: D-096-2013.